Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,309,421
-
Share change
-
-53,368
-
Total reported value
-
$160,091,597
-
Put/Call ratio
-
45%
-
Price per share
-
$5.28
-
Number of holders
-
63
-
Value change
-
+$1,291,086
-
Number of buys
-
31
-
Number of sells
-
27
Institutional Holders of ADAMAS PHARMACEUTICALS INC - COM (ADMS) as of Q2 2021
As of 30 Jun 2021,
ADAMAS PHARMACEUTICALS INC - COM (ADMS) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,309,421 shares.
The largest 10 holders included
FMR LLC, ARMISTICE CAPITAL, LLC, Stonepine Capital Management, LLC, AIGH Capital Management LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, Opaleye Management Inc., Swedbank AB, COOPER CREEK PARTNERS MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.